EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept

Aurelio Seidita, Alessandra Giuliano, Maurizio Soresi, Marta Chiavetta, Emilio Nardi, Giuseppe Mogavero, Giulio Giannone, Antonio Carroccio iD, Pasquale Mansueto

Internal and Emergency Medicine · 2024

DOI: 10.1007/s11739-024-03595-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Internal and Emergency Medicine, 2024. Verfasst von Aurelio Seidita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Internal Medicine, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", Via Trabucco, 180, 90146, Palermo, Italy. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Feces, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Università degli Studi di Palermo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Some data suggest the existence of intestinal inflammation in patients with non-celiac wheat sensitivity (NCWS). We aimed to verify whether fecal calprotectin (FCP), a marker of intestinal inflammation, could be used to confirm this inflammatory status and to test its diagnostic performance in differentiating NCWS from irritable bowel syndrome/functional dyspepsia (IBS/FD). We conducted a multicenter study, comparing NCWS patients, diagnosed by a double-blind placebo-controlled wheat challenge, with IBS/FD subjects. In the retrospective phase, FCP values were analyzed to define the prevalence of its positivity and its role as a NCWS diagnostic biomarker. In the prospective phase we tested the effects of a strict 6-month wheat-free diet (WFD) on FCP values. 31.3% ( n = 63/201) of NCWS patients had above normal FCP values (NCWS FCP +), whereas all IBS/FD patients proved negative (P = 0.0001). FCP using a cut-off value > 41 µg/g showed a 58.6% sensitivity and a 98.0% specificity (AUC 0.755, 95% C.I. 0.702–0.837) in distinguishing NCWS from IBS/FD patients. Of the 63 NCWS FCP+, 65.1% had negative FCP values after ≥ 6 months of WFD, with a significant reduction in FCP values ( P < 0.0001). All NCWS FCP- subjects still preserved negative FCP values after ≥ 6 months of WFD. Our study showed that FCP can be a useful but supplementary diagnostic marker for differentiating between NCWS and IBS/FD. Strict WFD adherence reduced FCP values, normalizing them in 65.1% of NCWS FCP + subjects. These data suggest the existence of two NCWS subgroups: NCWS FCP + characterized by a probable predominantly inflammatory/immunologic pattern and NCWS FCP− featuring non-immuno-mediated etiopathogenetic mechanisms. (Registration number NCT01762579).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocyte L1 Antigen ComplexFecesBiomarkersHumansFemaleMaleAdultMiddle AgedIrritable Bowel SyndromeProspective StudiesWheat HypersensitivityDouble-Blind MethodRetrospective StudiesTriticum

Stichwörter der Autor:innen

Diagnostic biomarkerFecal calprotectinGluten-free dietInnate immune responseIntestinal inflammatory responseNon-celiac wheat sensitivity

Substanzen

Leukocyte L1 Antigen ComplexBiomarkers

Autor:innen und Institutionen

  • Unit of Internal Medicine, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", Via Trabucco, 180, 90146, Palermo, Italy.
  • Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
  • Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Palermo, Italy.
  • Unit of Internal Medicine, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
  • Unit of Internal Medicine II, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
  • Unit of Gastroenterology, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", Palermo, Italy.

ORCID-Profile: Antonio Carroccio

Förderung

  • Ministero della Salute
  • Università degli Studi di Palermo

Zitieren

APA

Seidita, A., Giuliano, A., Soresi, M., Chiavetta, M., Nardi, E., Mogavero, G., Giannone, G., Carroccio, A., & Mansueto, P. (2024). Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept. Internal and Emergency Medicine. https://doi.org/10.1007/s11739-024-03595-7

Vancouver

Seidita A, Giuliano A, Soresi M, Chiavetta M, Nardi E, Mogavero G, et al. Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept. Internal and Emergency Medicine. 2024. doi:10.1007/s11739-024-03595-7

BibTeX
@article{Seidita2024,
  author = {Seidita, Aurelio and Giuliano, Alessandra and Soresi, Maurizio and Chiavetta, Marta and Nardi, Emilio and Mogavero, Giuseppe and Giannone, Giulio and Carroccio, Antonio and Mansueto, Pasquale},
  title = {Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept},
  journal = {Internal and Emergency Medicine},
  year = {2024},
  doi = {10.1007/s11739-024-03595-7}
}
Kostenlos starten →